Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence-Reference-Cited by-同舟云学术

Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence

Published:2023-12-19 Issue: Volume: Page:
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Dieudonné Arnaud^ORCID,Bailly Clément,Cachin Florent,Edet-Sanson Agathe,Kraeber-Bodéré Françoise,Hapdey Sébastien,Merlin Charles,Robin Philippe,Salaun Pierre-Yves,Schwartz Paul,Tonnelet David,Vera Pierre,Courbon Frédéric,Carlier Thomas

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-023-06568-8.pdf

Reference39 articles.

1. Sjögreen-Gleisner K et al. EFOMP policy statement NO. 19: dosimetry in nuclear medicine therapy – molecular radiotherapy. Physica Medica 2023; 103166. https://doi.org/10.1016/j.ejmp.2023.103166

2. Chiesa C, et al. The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. Eur J Nucl Med Mol Imaging. 2017;44(11):1783–6. https://doi.org/10.1007/s00259-017-3707-3.

3. Konijnenberg M, et al. EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy. Eur J Nucl Med Mol Imaging. 2021;48(1):67–72. https://doi.org/10.1007/s00259-020-05038-9.

4. Kappadath SC, Mikell J, Balagopal A, Baladandayuthapani V, Kaseb A, Mahvash A. Hepatocellular carcinoma tumor dose response after 90Y-radioembolization with glass microspheres using 90Y-SPECT/CT-based voxel dosimetry. Int J Radiat Oncol Biol Phys. 2018;102(2):451–61. https://doi.org/10.1016/j.ijrobp.2018.05.062.

5. Hermann A-L et al. Relationship of tumor radiation–absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90 Y in the SARAH Study. Radiology 2020; 191606. https://doi.org/10.1148/radiol.2020191606

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer;Scientific Reports;2024-08-27

2. Physics for molecular radiotherapy – The battle between science and simplicity;Physica Medica;2024-08

3. Lutetium-177-Prostate-Specific Membrane Antigen Radioligand Therapy: What Is the Value of Post-Therapeutic Imaging?;Biomedicines;2024-07-08

4. A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry;Frontiers in Oncology;2024-02-26